PDF(543 KB)
Preliminary clinical study on optimizing recombinant human tumor necrosis factor-d receptor Ⅱ:Fc treatment for patients with active rheumatoid arthritis based on chronobiology
WANG Zhi-qiang, GONG Cai-xia, ZHANG Xiao-gang, MA Xu, ZHANG Ming-ming, LIU Yan-qing, GU Jian-fang, LI Zhen-bin
Chinese Journal of Hospital Pharmacy ›› 2020, Vol. 40 ›› Issue (3) : 301-304.
PDF(543 KB)
PDF(543 KB)
Preliminary clinical study on optimizing recombinant human tumor necrosis factor-d receptor Ⅱ:Fc treatment for patients with active rheumatoid arthritis based on chronobiology
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
